Adenovirus-delivered antisense RNA and shRNA exhibit different silencing efficiencies for the endogenous transforming growth factor-beta (TGF-beta) type II receptor

DOI	Resolve DOI: https://doi.org/10.1089/oli.2006.16.2
Author	Search for: Ogorelkova, Miroslava¹; Search for: Zwaagstra, John¹; Search for: Elahi, Seyyed Mehdy¹; Search for: Dias, Christel¹; Search for: Guilbaut, Claire¹; Search for: Lo, Rita¹; Search for: Collins, Cathy¹; Search for: Jaramillo, Maria¹; Search for: Mullick, Alaka¹; Search for: O'Connor-McCourt, Maureen¹; Search for: Massie, Bernard¹
Affiliation	National Research Council Canada. NRC Biotechnology Research Institute
Format	Text, Article
Subject	biotechnology; Cells; crossector; Hela Cells; pharmaceutical; Protein; Rna; therapy; Transforming Growth Factor beta
Publication date	2006
In	Oligonucleotides 16, no. 1: 2–14.
Language	English
NRC number	47756
NPARC number	3539107
Export citation	Export as RIS
Report a correction	Report a correction (opens in a new tab)
Record identifier	b8dacabf-51f8-4595-a4da-024d2f3845f8
Record created	2009-03-01
Record modified	2020-04-22